People with schizophrenia often take strong antipsychotics that control symptoms but frequently cause rapid weight gain, high blood sugar, and a ...

Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

Recent clinical research indicates that semaglutide may effectively reverse weight gain and blood sugar issues caused by ...

The ingestible capsule is about the size of a multivitamin, and once swallowed, it expands into a star shape that helps it remain in the stomach until all of the drug is released. CAMBRIDGE, MA -- For ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with schizophrenia, it can be especially difficult. That’s because schizophrenia affects ...

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

Common acne medications show surprising potential in lowering schizophrenia risk among vulnerable youth. Research suggests ...